Earnings
PTCT
44.64
+0.95%
0.42
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
208.81M
894.84M
--
69.93M
--
--
0.00
--
18.70M
--
39.47M
--
1.23B
118.24M
--
--
--
82.34M
715.33M
--
60.62M
976.53M
2.21B
--
18.66M
0.00
--
--
--
54.33M
--
91.98M
--
--
--
90.06M
277.33M
990.94M
--
--
136.74M
321.29M
1.45B
1.73B
70.00K
2.17B
-1.63B
--
--
--
481.98M
481.98M
2.21B
FY 2019-12-31
288.03M
398.54M
--
55.54M
--
--
0.00
--
19.29M
--
17.90M
--
779.28M
35.24M
--
--
--
82.34M
710.50M
--
16.41M
844.50M
1.62B
--
10.32M
0.00
--
--
--
41.16M
--
69.95M
--
--
--
94.42M
235.86M
293.86M
--
--
130.86M
368.87M
793.60M
1.03B
62.00K
1.80B
-1.19B
--
--
--
594.33M
594.33M
1.62B
FY 2018-12-31
169.50M
58.09M
--
67.91M
--
--
0.00
--
16.12M
--
9.25M
--
320.86M
12.69M
--
--
--
82.34M
701.03M
--
2.30M
798.37M
1.12B
--
6.00M
0.00
--
--
--
94.57M
--
27.63M
--
--
--
26.93M
166.80M
141.35M
--
--
122.03M
338.32M
601.70M
768.50M
51.00K
1.29B
-938.92M
--
--
--
350.73M
350.73M
1.12B
FY 2017-12-31
111.79M
79.45M
--
40.39M
--
--
0.00
--
10.75M
--
6.67M
--
249.06M
8.38M
--
--
--
--
132.99M
--
1.22M
142.59M
391.65M
--
15.28M
0.00
--
--
--
43.45M
--
17.71M
--
--
--
5.60M
82.05M
144.97M
--
--
--
8.20M
153.17M
235.22M
42.00K
966.53M
-814.11M
--
--
--
156.44M
156.44M
391.65M
FY 2016-12-31
58.32M
173.34M
--
24.93M
--
--
0.00
--
--
--
4.69M
--
261.29M
7.43M
--
--
--
--
--
--
630.00K
8.06M
269.35M
--
6.30M
0.00
--
--
--
28.81M
--
13.65M
--
--
--
865.00K
49.62M
98.22M
--
--
--
1.92M
100.14M
149.76M
34.00K
856.14M
-735.11M
--
--
--
119.58M
119.58M
269.35M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out PTCT latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze PTC Therapeutics recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.